Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-057513

President and CEO acquired 65,153 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fordyce Marshall · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-16 Exercise or conversion : show line 1 in the form +5,153 $2.32 $11,942 186,303 D
2022-11-16 Exercise or conversion : show line 2 in the form +60,000 $2.90 $173,808 246,303 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-11-16 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −5,153 516 D
2022-11-16 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −60,000 887,212 D
Loading xslF345X03/doc4.xml…